Position in BSX
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$540,277
+$223,811 QoQ
Shares Held
8,610
+159.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Pallas Capital Advisors LLC holds $361,562,391 across 14 Medical Devices names. BSX ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BRKR |
Bruker Corp
|
9,481,821 | $342,483,374 | |
| 2 | ABT |
Abbott Laboratories
|
86,541 | $8,885,164 | |
| 3 | SYK |
Stryker Corp
|
18,559 | $6,098,301 | |
| 4 | MDT |
Medtronic plc
|
16,707 | $1,447,661 | |
| 5 | EW |
Edwards Lifesciences Corp
|
7,891 | $631,911 | |
| 6 | PODD |
Insulet Corp
|
2,901 | $608,745 | |
| 7 | BSX |
Boston Scientific Corp
This page
|
8,610 | $540,277 | |
| 8 | PEN |
Penumbra Inc
|
1,061 | $348,400 |
All Filings in BSX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $540,277 | 8,610 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $316,466 | 3,319 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $672,084 | 6,884 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $661,967 | 6,163 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $406,647 | 4,031 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $363,800 | 4,073 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $370,060 | 4,416 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $339,306 | 4,406 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $337,587 | 4,929 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $234,188 | 4,051 | Shares | Sole | 2024-01-22 | |
| No filing history on record for this holder in this stock. | ||||||